In 2014, 41 new drugs were registered by the FDA, a record year for pharmaceutical innovation

There is also an Italian presence among the 41 new approvals. It is Bracco which has obtained the OK from the FDA for Lumason (sulfur hexafluoride lipid microsphere), a radiopharmaceutical. However, not all companies celebrated. For example, Pfizer, which has significantly reduced its research budget in recent years, and GlaxoSmithKline also has little to celebrate

5 Gennaio 2014 – PHARMASTAR

Lo scorso anno, l’Fda ha dato il via libera a 41 nuovi farmaci, il livello più alto per l’agenzia dal 1996, quando ne  furono approvati ben 53. Il dato del 2014 è decisamente migliore rispetto al numero di farmaci approvato dall’agenzia nel 2013, solo 29.

To stay on the numbers, the 2014 figure is also clearly higher than the average of the last 10 years (24) , and even of the previous decade, that of the 1990s (31). In short, an excellent fact that we hope will also bode well for the years to come. There are still many pathologies awaiting an effective and safe response.

Per l’Europa, l’Agenzia europea per i medicinali, che nella sua lista di nuove approvazioni comprende anche i farmaci generici, l’anno scorso ha approvato 82 nuovi farmaci, dal 79 nel 2013 e 57 nel 2012.

Dei nuovi farmaci approvati lo scorso anno dall’Fda, quasi il 40 per cento erano trattamenti per le malattie rare, il dato più alto mai registrato in Usa. Tra questi farmaci vi sono l’anticorpo anti-CD19 blinatumomab (Amgen), che ha ottenuto l’approvazione accelerata dalla FDA per il trattamento della leucemia linfoblastica acuta cromosoma Philadelphia-negativa e la terapia della lipodistrofia (metreleptin di Aegerion Pharmaceuticals.

There is also an Italian presence among the 41 new approvals. It is Bracco which has obtained the OK from the FDA for Lumason (sulfur hexafluoride lipid microsphere), a radiopharmaceutical indicated for patients for whom it is difficult to obtain readable echocardiograms with ultrasound alone. Lumason is a contrast medium made up of gas-filled microspheres that reflect sound waves to improve the image and allow the clinician to visualize the patient's heart more clearly. This enables clearer imaging of the left ventricle and endocardium

( … continua)

List of FDA approved drugs in 2014